Cargando…
Bioprinting Vasculature: Materials, Cells and Emergent Techniques
Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major mil...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747573/ https://www.ncbi.nlm.nih.gov/pubmed/31450791 http://dx.doi.org/10.3390/ma12172701 |
_version_ | 1783451930058555392 |
---|---|
author | Tomasina, Clarissa Bodet, Tristan Mota, Carlos Moroni, Lorenzo Camarero-Espinosa, Sandra |
author_facet | Tomasina, Clarissa Bodet, Tristan Mota, Carlos Moroni, Lorenzo Camarero-Espinosa, Sandra |
author_sort | Tomasina, Clarissa |
collection | PubMed |
description | Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major milestone if tissues bigger than approximately 200 µm are to be transplanted. Cell survival and homeostasis is to a large extent conditioned by the oxygen and nutrient transport (as well as waste removal) by blood vessels on their proximity and spontaneous vascularization in vivo is a relatively slow process, leading all together to necrosis of implanted tissues. Thus, in vitro vascularization appears to be a requirement for the advancement of the field. One of the main approaches to this end is the formation of vascular templates that will develop in vitro together with the targeted engineered tissue. Bioprinting, a fast and reliable method for the deposition of cells and materials on a precise manner, appears as an excellent fabrication technique. In this review, we provide a comprehensive background to the fields of vascularization and bioprinting, providing details on the current strategies, cell sources, materials and outcomes of these studies. |
format | Online Article Text |
id | pubmed-6747573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67475732019-09-27 Bioprinting Vasculature: Materials, Cells and Emergent Techniques Tomasina, Clarissa Bodet, Tristan Mota, Carlos Moroni, Lorenzo Camarero-Espinosa, Sandra Materials (Basel) Review Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major milestone if tissues bigger than approximately 200 µm are to be transplanted. Cell survival and homeostasis is to a large extent conditioned by the oxygen and nutrient transport (as well as waste removal) by blood vessels on their proximity and spontaneous vascularization in vivo is a relatively slow process, leading all together to necrosis of implanted tissues. Thus, in vitro vascularization appears to be a requirement for the advancement of the field. One of the main approaches to this end is the formation of vascular templates that will develop in vitro together with the targeted engineered tissue. Bioprinting, a fast and reliable method for the deposition of cells and materials on a precise manner, appears as an excellent fabrication technique. In this review, we provide a comprehensive background to the fields of vascularization and bioprinting, providing details on the current strategies, cell sources, materials and outcomes of these studies. MDPI 2019-08-23 /pmc/articles/PMC6747573/ /pubmed/31450791 http://dx.doi.org/10.3390/ma12172701 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tomasina, Clarissa Bodet, Tristan Mota, Carlos Moroni, Lorenzo Camarero-Espinosa, Sandra Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title_full | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title_fullStr | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title_full_unstemmed | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title_short | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
title_sort | bioprinting vasculature: materials, cells and emergent techniques |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747573/ https://www.ncbi.nlm.nih.gov/pubmed/31450791 http://dx.doi.org/10.3390/ma12172701 |
work_keys_str_mv | AT tomasinaclarissa bioprintingvasculaturematerialscellsandemergenttechniques AT bodettristan bioprintingvasculaturematerialscellsandemergenttechniques AT motacarlos bioprintingvasculaturematerialscellsandemergenttechniques AT moronilorenzo bioprintingvasculaturematerialscellsandemergenttechniques AT camareroespinosasandra bioprintingvasculaturematerialscellsandemergenttechniques |